ArticleGastroenterology clinics of North America2014
Eosinophilic esophagitis: historical perspective on an evolving disease.
Article in Gastroenterology clinics of North America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 29 citations in OpenAlex.
- Esophageal microbiome in eosinophilic esophagitis.PloS one · 2015Trial
- The Potential Link Between Eosinophilic Esophagitis and Food Allergy: Inflammatory Pathogenesis and Management.Journal of inflammation research · 2026Review
- The Overlap of Allergic Disorders and Upper Gastrointestinal Symptoms: Beyond Eosinophilic Esophagitis.Nutrients · 2025Observational
- Article
- Allergies Come Clean: The Role of Detergents in Epithelial Barrier Dysfunction.Current allergy and asthma reports · 2023Review
- Allergen-induced NLRP3/caspase1/IL-18 signaling initiate eosinophilic esophagitis and respective inhibitors protect disease pathogenesis.Communications biology · 2023Article
- Clinical Features of Eosinophilic Esophagitis: A Single Center Experience in Ecuador.Pediatric gastroenterology, hepatology & nutrition · 2022Article
- Models and Tools for Investigating Eosinophilic Esophagitis at the Bench.Frontiers in immunology · 2022Review
- Eosinophilic oesophagitis: improving diagnosis and therapy - reducing the burden of repeated endoscopy.Frontline gastroenterology · 2022Article
- Eosinophilic esophagitis: an interdisciplinary clinical problem.Postepy dermatologii i alergologii · 2021Review
- Article
- The Global Face of Eosinophilic Esophagitis: Advocacy and Research Groups.Clinical reviews in allergy & immunology · 2018Review
- Emerging Insights into the Esophageal Microbiome.Current treatment options in gastroenterology · 2018Review
- Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE).Cellular and molecular gastroenterology and hepatology · 2018Article
- Prevalence of eosinophilic oesophagitis in adults presenting with oesophageal food bolus obstruction.World journal of gastrointestinal pharmacology and therapeutics · 2015Article
- Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis.Annals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
Initial case series describing children and adults with symptoms related to esophageal dysfunction and dense esophageal eosinophilia lead to recognition of a "new" disease, eosinophilic esophagitis (EoE). Clinical, basic, and translational studies have provided a deeper understanding of this somewhat enigmatic disease that mechanistically is defined as an antigen-driven condition limited to the esophagus. This article summarizes many of the key historical features of EoE and provides a glimpse of potential future developments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.